Prucalopride is a prescription medication used to treat chronic idiopathic constipation (CIC), a condition characterized by difficulty in passing stools without a known cause. It works by increasing peristalsis, the contractions in the colon, which helps stimulate bowel movements. As a selective serotonin 5-HT4 receptor agonist, prucalopride enhances the motility of the gastrointestinal tract, making it effective for increasing the frequency of bowel movements in patients with chronic constipation. This medication is available only with a doctor's prescription.
Parent: Prucalopride
Parent: Prucalopride
Parent: Prucalopride
Parent: Prucalopride
Parent: Prucalopride
Parent: Prucalopride
Parent: Prucalopride
Parent: Prucalopride
Parent: Prucalopride
Parent: Prucalopride
Parent: Prucalopride
Parent: Prucalopride
Parent: Prucalopride
Parent: Prucalopride
Parent: Prucalopride
Parent: Prucalopride
Parent: Prucalopride Succinate
Parent: Prucalopride
Parent: Prucalopride
Parent: Prucalopride
Parent: Prucalopride
Parent: Prucalopride
Parent: Prucalopride
During the production and storage of prucalopride, impurities can develop that must be carefully monitored to ensure the medication’s safety and efficacy. Regulatory agencies such as the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) set stringent guidelines for acceptable impurity levels in pharmaceutical products.
Prucalopride belongs to a class of medications called selective serotonin 5-HT4 receptor agonists. It is a prokinetic agent specifically designed to treat chronic idiopathic constipation by enhancing the motility of the gastrointestinal tract.
No, prucalopride is not a stimulant laxative. While stimulant laxatives work by irritating the intestines or drawing water into the colon, prucalopride works by directly stimulating serotonin 5-HT4 receptors to increase peristalsis (colon contractions) naturally, without causing irritation or dependency.
No, prucalopride is not an antidepressant. Although it acts on serotonin receptors, its effects are localized in the gastrointestinal tract. It does not affect mood or serotonin levels in the brain, unlike antidepressants that target serotonin to improve mood.
Prucalopride is an agonist, specifically a selective serotonin 5-HT4 receptor agonist. By activating these receptors in the gastrointestinal tract, prucalopride enhances bowel motility and promotes natural bowel movements in patients suffering from chronic constipation.
